Cardiomyopathy
146
19
20
90
Key Insights
Highlights
Success Rate
89% trial completion (above average)
Published Results
29 trials with published results (20%)
Research Maturity
90 completed trials (62% of total)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
7.5%
11 terminated out of 146 trials
89.1%
+2.6% vs benchmark
12%
18 trials in Phase 3/4
32%
29 of 90 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 90 completed trials
Clinical Trials (146)
Characterization of Patients With Uncommon Presentations and/or Uncommon Diseases Associated With the Cardiovascular System
Effectiveness and Treatment Patterns of Mavacamten in Patients With Obstructive Hypertrophic Cardiomyopathy in Japan (MANAGE-HCM)
Efficacy of Dotarem® (Gd-DOTA) Versus Gadovist® (Gd-DO3A-butrol) for Late Gadolinium Enhancement Cardiac Magnetic Resonance
A Bioequivalence Study of Two Formulations of HRS-1893 Tablets in Healthy Participants
Study of the Effect of SNPs in p53 and p53 Response Elements on the Inflammatory Response to DNA Damage
A Study Of Deep Learning For Echo Analysis, Tracking, And Evaluation
Clinical Course Of Disease In Participants With FA-CM
A Phase I Trial on the Relative Bioavailability and Food Effect of HRS-1893 Tablets in Healthy Subjects
Pediatric Lead Extractability and Survival Evaluation (PLEASE)
Cardiac and Metabolic Effects of Semaglutide in Heart Failure With Preserved Ejection Fraction
French Registry: Late Gadolinium Enhancement in Hypertrophic Cardiomyopathy
A Study Assessing Arrhythmia Mapping With a Multi-Electrode Mapping Catheter
TRPC6 Characterization to Predict and Prevent Chemotherapy Related Cardiomyopathy and Heart Failure With Breast Cancer
Donor Bone Marrow Derived Mesenchymal Stem Cells in Controlling Heart Failure in Patients With Cardiomyopathy Caused by Anthracyclines
IVTCC 2.0: A Prospective Multicenter Ventricular Tachycardia Catheter Ablation Registry
A Study of ASP2016 in Adults Who Have Heart Disease Associated With Friedreich Ataxia
Nebivolol for the Prevention of Left Ventricular Systolic Dysfunction in Patients With Duchenne Muscular Dystrophy
Molecular Imaging of Primary Amyloid Cardiomyopathy
AI-SCREENDCM Decentralized Clinical Trial - Pilot Study
Mechanisms of Improvement With Beta-Blocker Treatment in Heart Failure